Cargando…
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409037/ https://www.ncbi.nlm.nih.gov/pubmed/33882638 http://dx.doi.org/10.3324/haematol.2020.276865 |
| _version_ | 1783746915359260672 |
|---|---|
| author | Burger, Renate Otte, Anna Brdon, Jan Peipp, Matthias Gramatzki, Martin |
| author_facet | Burger, Renate Otte, Anna Brdon, Jan Peipp, Matthias Gramatzki, Martin |
| author_sort | Burger, Renate |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8409037 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84090372021-09-08 Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth Burger, Renate Otte, Anna Brdon, Jan Peipp, Matthias Gramatzki, Martin Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-04-22 /pmc/articles/PMC8409037/ /pubmed/33882638 http://dx.doi.org/10.3324/haematol.2020.276865 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Burger, Renate Otte, Anna Brdon, Jan Peipp, Matthias Gramatzki, Martin Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title | Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title_full | Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title_fullStr | Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title_full_unstemmed | Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title_short | Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| title_sort | dual intracellular targeting by ruxolitinib and the mcl-1 inhibitor s63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409037/ https://www.ncbi.nlm.nih.gov/pubmed/33882638 http://dx.doi.org/10.3324/haematol.2020.276865 |
| work_keys_str_mv | AT burgerrenate dualintracellulartargetingbyruxolitinibandthemcl1inhibitors63845ininterleukin6dependentmyelomacellsblocksinvivotumorgrowth AT otteanna dualintracellulartargetingbyruxolitinibandthemcl1inhibitors63845ininterleukin6dependentmyelomacellsblocksinvivotumorgrowth AT brdonjan dualintracellulartargetingbyruxolitinibandthemcl1inhibitors63845ininterleukin6dependentmyelomacellsblocksinvivotumorgrowth AT peippmatthias dualintracellulartargetingbyruxolitinibandthemcl1inhibitors63845ininterleukin6dependentmyelomacellsblocksinvivotumorgrowth AT gramatzkimartin dualintracellulartargetingbyruxolitinibandthemcl1inhibitors63845ininterleukin6dependentmyelomacellsblocksinvivotumorgrowth |